Last updated: 2026-09-05 07:58:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Intercure Ltd. (INCR) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $5.45, with a market capitalisation of $81.02M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.40 to $8.45. This page covers its latest market performance, valuation, price trends and company information.
$81.02M | |
$5.33 | |
$305.50 | |
$3.40 | |
$5.26 | |
5.45K | |
-- | |
-- | |
$8.45 | |
$3.40 | |
-- | |
-- |
Intercure Ltd. (INCR) last closed at $5.26 as of 2026-09-04 23:31:00, unchanged from the previous close of $5.26.
During the latest regular trading session, INCR traded between $3.40 and $305.50, with a volume of 5.45K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, Intercure Ltd. (INCR) moved from $5.79 to $5.45, representing a decline of 5.96% ($0.34).
The stock traded between $5.15 and $6.16 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 13.70 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 40.5%
INCR is currently trading at $5.45, placing it 40.5% of the way from its 52-week low of $3.40 to its 52-week high of $8.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
| Employees | 285 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Intercure Ltd. (INCR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.